Squarepoint Ops LLC Grows Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Squarepoint Ops LLC increased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 14,686.6% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 107,055 shares of the company’s stock after acquiring an additional 106,331 shares during the period. Squarepoint Ops LLC’s holdings in Henry Schein were worth $6,862,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in HSIC. Summit Securities Group LLC bought a new position in Henry Schein during the second quarter valued at approximately $31,000. Beach Investment Counsel Inc. PA bought a new position in Henry Schein during the second quarter valued at approximately $37,000. Blue Trust Inc. boosted its stake in Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after buying an additional 475 shares during the last quarter. Mather Group LLC. boosted its stake in Henry Schein by 16.8% during the second quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock valued at $96,000 after buying an additional 216 shares during the last quarter. Finally, Palisade Asset Management LLC bought a new position in Henry Schein during the first quarter valued at approximately $113,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insider Activity at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.14% of the stock is currently owned by insiders.

Henry Schein Trading Up 3.3 %

NASDAQ:HSIC opened at $73.22 on Monday. Henry Schein, Inc. has a 12-month low of $60.01 and a 12-month high of $82.63. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. The firm has a market cap of $9.38 billion, a PE ratio of 24.74, a price-to-earnings-growth ratio of 2.01 and a beta of 0.86. The stock has a fifty day moving average price of $70.10 and a 200 day moving average price of $70.18.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The company had revenue of $3.10 billion for the quarter, compared to analysts’ expectations of $3.27 billion. During the same period last year, the firm earned $1.31 earnings per share. Henry Schein’s quarterly revenue was up .0% on a year-over-year basis. Sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on HSIC shares. Barrington Research reaffirmed an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a research note on Friday, September 20th. Piper Sandler reissued an “overweight” rating and issued a $86.00 price target on shares of Henry Schein in a research report on Friday, June 21st. JPMorgan Chase & Co. reduced their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Finally, Evercore ISI reduced their target price on Henry Schein from $72.00 to $70.00 and set an “in-line” rating on the stock in a research report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, six have given a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $77.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.